Critical design criteria for engineering a nanoparticulate HIV-1 vaccine

S Thalhauser, D Peterhoff, R Wagner… - Journal of Controlled …, 2020 - Elsevier
Inducing a long-lasting as well as broad and potent immune response by generating broadly
neutralizing antibodies is a major goal and at the same time the main challenge of …

Potency of a scalable nanoparticulate subunit vaccine

D Qiao, L Liu, Y Chen, C Xue, Q Gao, HQ Mao… - Nano …, 2018 - ACS Publications
Nanoparticulate vaccines can potentiate immune responses by site-specific drainage to
lymph nodes (LNs). This approach may benefit from a nanoparticle engineering method with …

[HTML][HTML] Non-invasive administration of biodegradable nano-carrier vaccines

MA Kalam, AA Khan, A Alshamsan - American journal of …, 2017 - ncbi.nlm.nih.gov
Polymeric nanoparticulate carriers play an important role and holding a significant potential
for the development of novel immunomodulatory agents as easily they are taken up by …

The potential of nanoparticles for the immunization against viral infections

V Sokolova, AM Westendorf, J Buer, K Überla… - Journal of Materials …, 2015 - pubs.rsc.org
Vaccination has a great impact on the prevention and control of infectious diseases.
However, there are still many infectious diseases for which an effective vaccine is missing …

Polymer-based nanoparticles as modern vaccine delivery systems

L Lambricht, C Peres, H Florindo, V Préat… - … and nanotechnology in …, 2017 - Elsevier
Nanoparticulate carriers are particularly promising and versatile in stimulating immune
response. Indeed, nanotechnology allows the creation of structures that exploit the inherent …

Presentation of HIV-1 envelope trimers on the surface of silica nanoparticles

S Thalhauser, D Peterhoff, R Wagner… - Journal of Pharmaceutical …, 2020 - Elsevier
Inducing immune responses protecting from HIV infection or at least controlling replication
poses a huge challenge to modern vaccinology. An increasingly discussed strategy to elicit …

Nanoparticulate carriers used as vaccine adjuvant delivery systems

N Wang, R Qian, T Liu, T Wu… - Critical Reviews™ in …, 2019 - dl.begellhouse.com
Vaccination plays a crucial role in the control of infectious diseases, but often fails to
eradicate certain refractory infections for which the development of an effective vaccine is …

Nanoparticulate drug carriers for delivery of HIV/AIDS therapy to viral reservoir sites

TK Vyas, L Shah, MM Amiji - Expert opinion on drug delivery, 2006 - Taylor & Francis
Providing the optimum treatment of AIDS is a major challenge in the 21st Century. HIV is
localised and harboured in certain inaccessible compartments of the body, such as the CNS …

Presentation of HIV-1 envelope glycoprotein trimers on diverse nanoparticle platforms

PJM Brouwer, RW Sanders - Current Opinion in HIV and AIDS, 2019 - journals.lww.com
It is becoming increasingly clear that HIV-1 vaccine research might benefit greatly from using
nanoparticles presenting Env trimers, particularly during the priming stage of immunization …

Nano-Particulate Platforms for Vaccine Delivery to Enhance Antigen-Specific CD8+ T-Cell Response

J Sharma, CS Carson, T Douglas, JT Wilson… - … Design: Methods and …, 2022 - Springer
Vaccines remain the most effective way to protect populations against deathly infectious
diseases. Several disadvantages associated with the traditional vaccines that use whole …